Top Markets
#1 Siren Siren +38.57%
#2 RedStone RedStone +23.03%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Cysic Cysic +15.54%
#5 Ocean Protocol Ocean Protocol +15.53%
#6 Verus Coin Verus Coin +13.51%
#7 Arowana Arowana +13.51%
#8 KUB Coin KUB Coin +13.09%
#9 Perle Perle +12.59%
#10 Wiki Cat Wiki Cat +9.55%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Rang in Aktien #32096
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Aktienkurs
$0.21483059
Zuletzt synchronisiert: 2024-05-07
Marktkapitalisierung
$11.13M
Veränderung (1 Tag)
0.34%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Antibe Therapeutics Inc. (ATE)

Kategorie

Healthcare
Aktien-Split-Historie für Antibe Therapeutics Inc. (ATE)
Die Aktie Antibe Therapeutics Inc. (Symbol: ATE) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 18, 2026 statt.
Eine ATE-Aktie, die vor dem Aug 18, 2026 gekauft wurde, entspricht heute 0 ATE-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 9 x285
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 9 x162
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 7 x127
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2 x4
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 3 x12
US